19 September 2016 - The agency approves a new medicine after an ugly bureaucratic brawl.
Miracles happen. The FDA approved a drug for muscular dystrophy this week after months of delay and bureaucratic infighting. This is a triumph for scientific innovation, and for young men who will live better and more independently—if the bureaucracy doesn’t strike back.